Behbahani Ali
Director at CRSP; Director, 10% owner at NEUE; Director at ADAPY, and 4 more
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Sep 17, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 7
- Filed as an executive or holder
Companies
- CRSPCRISPR Therapeutics AGDirector
- NEUENeueHealth, Inc.Director, 10% owner
- ADAPYAdaptimmune Therapeutics PLCDirector
- CVRXCVRx, Inc.Officer
- GENOCEA BIOSCIENCES, INC.Director, 10% owner
- Metacrine, Inc.10% owner
- TRVITrevi Therapeutics, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ADAPY19.5M shares
- GENOCEA BIOSCIENCES, INC.10.4M shares
- Metacrine, Inc.497,270 shares
- CRSP13,679 shares
- NEUE3,915 shares
- TRVI564 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TRVIPlan not statedApr 3, 2020 2020
Sold 564 shares at $2.66 ($2k)
Behbahani Ali, 10% owner
Sold 0% of holdings ($15.8M position)5.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale Metacrine, Inc.Plan not statedDec 22, 2021 +628 days
Sold 497,270 shares at $0.99 ($494k)
Name not stated, 10% owner
Sold 16.2% of holdings ($3M position)2.6M shares leftFirst sale on recordFiling
- 3 Form 4 sale GENOCEA BIOSCIENCES, INC.UnusualMay 25, 2022 +154 days
Sold 10.4M shares at $0.0743 ($771k)
Behbahani Ali, Director, 10% owner
Sold 100% of holdings ($771k position)0 shares leftFirst sale on recordFiling
- 4 Form 144 notice CVRXNoticeNov 18, 2024 +908 days
Filed to sell 9 shares ($127)
Behbahani Ali, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice CVRXNoticeNov 29, 2024 +11 days
Filed to sell 21,837 shares ($334k)
Behbahani Ali, Officer
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale ADAPYUnusualAug 18, 2025 +262 days
Sold 19.5M shares at $0.0100 ($195k)
Behbahani Ali, Director
No 10b5-1 planSold 100% of holdings ($195k position)0 shares leftFirst sale on recordFiling
- 7 Form 4 sale NEUENo planOct 2, 2025 +45 days
Sold 3,915 shares at $6.75 ($26k)
Behbahani Ali, Director, 10% owner
No 10b5-1 planSold 0.2% of holdings ($15.3M position)2.3M shares leftFirst sale on recordFiling
- 8 Form 4 sale CRSPUnusualSep 17, 2026 +350 days
Sold 13,679 shares at $57.09 ($781k)
Behbahani Ali, Director
No 10b5-1 planSold 45.1% of holdings ($1.7M position)16,637 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Sep 21, 2026 | CRSP | Director | Form 4 sale | 13,679 | $781k | 45.1% | Unusual | SEC |
| Oct 2, 2025 | Oct 6, 2025 | NEUE | Director, 10% owner | Form 4 sale | 3,915 | $26k | 0.2% | No plan | SEC |
| Aug 18, 2025 | Aug 19, 2025 | ADAPY | Director | Form 4 sale | 19.5M | $195k | 100.0% | Unusual | SEC |
| Nov 29, 2024 | Nov 29, 2024 | CVRX | Officer | Form 144 notice | 21,837 | $334k | Notice | SEC | |
| Nov 18, 2024 | Nov 18, 2024 | CVRX | Officer | Form 144 notice | 9 | $127 | Notice | SEC | |
| May 25, 2022 | May 26, 2022 | GENOCEA BIOSCIENCES, INC. | Director, 10% owner | Form 4 sale | 10.4M | $771k | 100.0% | Unusual | SEC |
| Dec 22, 2021 | Dec 27, 2021 | Metacrine, Inc. | 10% owner | Form 4 sale | 497,270 | $494k | 16.2% | Plan not stated | SEC |
| Apr 3, 2020 | Apr 13, 2020 | TRVI | 10% owner | Form 4 sale | 564 | $2k | 0.0% | Plan not stated | SEC |